CURRENT RESEARCH - enrolling now

1. Surgical IIH Treatment Trial (SIGHT) for Idiopathic Intracranial Hypertention

 The National Eye Institue is sponsoring this NORDIC Investigator-initiated study to compare medical treatment and two types of surgical treatments for Idiopathic Intracranial Hypertension.

Find a list of doctors for the SIGHT studyenrolling now.  This trial is  being conducted by Neuro-Ophthalmologists in private practices and hospitals in the United States and Canada.

Read more from NORDIC on the background of this study.

 

2. Treatment Trial for Patients with previous, chronic Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)

Regenera Pharma and NORDIC are collaborating on a treatment trial to evaluate Regenera's novel drug, RPh201, an extract from a botanical source, to treat chronic Non-arteritic Anterior Ischemic Optic Neuropathy (NAION).

Find a list of doctors for the Regenera NAION study, enrolling now.  This trial is being conducted by Neuro-Ophthalmologists in private practices and hospitals in the United States.

Read more from NORDIC on the background of this study.